S
Stephanie Pedersen
Researcher at Princess Margaret Cancer Centre
Publications - 5
Citations - 65
Stephanie Pedersen is an academic researcher from Princess Margaret Cancer Centre. The author has contributed to research in topics: Biology & Cancer research. The author has an hindex of 1, co-authored 1 publications receiving 14 citations.
Papers
More filters
Journal ArticleDOI
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition Progression
Stephanie Lheureux,Stephanie Lheureux,Ana Oaknin,Swati Garg,Jeff Bruce,Ainhoa Madariaga,Neesha C. Dhani,Neesha C. Dhani,Valerie Bowering,Justin White,Sarah Accardi,Qian Tan,Marsela Braunstein,Katherine Karakasis,Iulia Cirlan,Stephanie Pedersen,Tiantiam Li,Lorena Fariñas-Madrid,Yeh Chen Lee,Zhihui Amy Liu,Trevor J. Pugh,Trevor J. Pugh,Trevor J. Pugh,Amit M. Oza,Amit M. Oza +24 more
TL;DR: This is currently the largest post-PARPi study identifying genomic mechanisms of resistance to PARPis and the activity of cediranib–olaparib varied according to the PARPi resistance mechanism.
Journal ArticleDOI
Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma
Derek Wong,Pingshan Luo,Nadia Znassi,Diana Paola Arteaga,Diana Gray,Arnavaz Danesh,Ming Han,Eric Y. Zhao,Stephanie Pedersen,Stephenie D. Prokopec,Yogi Sundaravadanam,Dax Torti,Kayla Marsh,Sareh Keshavarzi,Wei Xu,Hatem Krema,Anthony M. Joshua,Mark S. Butler,Trevor J. Pugh +18 more
TL;DR: In this article , the authors demonstrate integrated, longitudinal cfDNA sequencing using multi-omic approaches is more effective than unimodal analysis and support the use of frequent blood testing using comprehensive genomic, fragmentomic, and epigenomic techniques.
Journal ArticleDOI
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
Arash Nabbi,Arnavaz Danesh,Osvaldo Espin-Garcia,Stephanie Pedersen,Johanna Wellum,Ling Fu,Joseph N. Paulson,Birgit Geoerger,Lynley V. Marshall,Tanya M. Trippett,Gianluca Rossato,Trevor J. Pugh,Katherine E. Hutchinson +12 more
TL;DR: In this paper , an exploratory biomarker analysis of refractory tumors collected from pediatric patients before atezolizumab therapy (iMATRIX-atezolizumaab, NCT02541604 ).
Journal ArticleDOI
Abstract 6667: Pan-cancer assessment of tumour and peripheral T-cell receptor repertoire dynamics in patients treated with immune checkpoint inhibitors
Shirin Soleimani,Ben X. Wang,Stephanie Pedersen,Jenna Eagles,Mark S. Butler,Scott V. Bratman,Lillian L. Siu,Pamela S. Ohashi,Trevor J. Pugh +8 more
TL;DR: Soleimani et al. as mentioned in this paper used a Graph Neural Network (GNN) model to track the specificity-associated features of local and systemic TCR repertoires in response to ICB.
Journal ArticleDOI
Molecular classification of endometrial cancers using an integrative DNA sequencing panel (271)
Soyoun Rachel Kim,Leslie Oldfield,Osvaldo Espin-Garcia,Kathy Han,Danielle Vicus,Lua Eiriksson,Alicia A. Tone,Aaron Pollett,Emily Van de Laar,Stephanie Pedersen,Johanna Wellum,Marcus Q. Bernardini,Trevor Pugh,Sarah E. Ferguson +13 more
TL;DR: In this article , the Cancer Genome Atlas (TCGA) has identified four molecular subgroups of endometrial cancers (EC) with distinct differences in prognosis and response to adjuvant treatment.